NCT02645240

CompletedPhase 4

Predictive Factors of Intestinal Infraction in Acute Mesente...

Mansoura University Source

ClinicalTrials.gov

Compare

Other study identifiers

Sponsor study identifier

mansoura30

Study Type

interventional

Actual enrollment (reported)

97

Locations

1 country

Sites

1

Timeline

Study Start

October 2015

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

July 2017

Actual (reported)

Study Completion

August 2017

Actual (reported)

Brief Summary

The study aims to identify several factors that can accurately predict the incident of intestinal infraction in patients with mesenteric vascular occlusion or ischemia.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 97 participants
Study completion date: August 2017
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
October 2015
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
December 29, 2015
Actual (reported)
First Posted
January 1, 2016
Actual (reported)
Primary Completion
July 2017
Actual (reported)
Study Completion
August 2017
Actual (reported)

Last Updated: August 29, 2017
Status Verified: August 2017
Last Update Submitted: August 28, 2017

Conditions

Mesenteric Ischemia

Outcome Measures

Primary Outcomes (1)

Clinical improvement
Number of patients with resolved abdominal symptoms and incidence of patients developing shock
48 hours

Study Arms (1)

Heparin injection

EXPERIMENTAL

Injection of low molecular weight heparin in patients with acute mesenteric ischemia to assess outcome

Drug: Heparin injection

Interventions

Heparin injectionDrug

Intravenous heparin injection in patients with acute mesenteric ischemia and evaluating their response within 24 hours

Also known as: Low molecular weight heparin injection

Heparin injection

Eligibility Criteria

Age16 Years - 85 Years

Sexall

Healthy VolunteersNo

Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

Patients with acute mesenteric Ischemia

You may not qualify if:

Sponsors & Collaborators

Mansoura University
Otherlead

Study Sites (1)

Mansoura university hospital

Al Mansurah, Dakahlia Governorate, Egypt

MeSH Terms

Conditions

Mesenteric Ischemia

Interventions

HeparinHeparin, Low-Molecular-Weight

Condition Hierarchy (Ancestors)

Intestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesPeritoneal DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

GlycosaminoglycansPolysaccharidesCarbohydrates

Study Officials

Sameh H Emile, M.D
Mansoura Univesity
PRINCIPAL INVESTIGATOR

Enrollment

97 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: phase 4
Allocation: NA
Masking: NONE
Purpose: DIAGNOSTIC
Intervention Model: SINGLE GROUP
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

December 29, 2015

First Posted

January 1, 2016

Study Start

October 2015

Date type not reported

This date has not been verified as actual or estimated.

NCT02493504

Effects of Heparin on Arteriovenous Fistula Patency

Phase 4Completed

NCT05247424

Pretreatment With Unfractionated Heparin for ST Elevation Myocardial Infarction

Phase 4Completed

NCT01634438

Heparin Dose for Radial Angiography

Phase 4Completed

NCT00253851

Does Thinning the Blood During Surgery Prevent Blood Clots Following Total Knee Replacement Surgery

Phase 4Completed

NCT01214772

The Effect of Heparin in Treatment IVF-ET Failure

Phase 4Completed

NCT06375616

Comparison of Nafamostat and Unfractionated Heparin in RRT for Sepsis Associated AKI

Phase 4Not Yet Recruiting

Patients with other causes of acute abdomen other than mesenteric Ischemia

Contact the study team to confirm eligibility.

Primary Completion

July 2017

Actual (reported)

Study Completion

August 2017

Actual (reported)

Last Updated

August 29, 2017

Record last verified: 2017-08

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT02645240
Data provider: ClinicalTrials.gov
Source updated: 2017-08-29
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:35:45 UTC

Locations

EG(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Study Arms (1)

Heparin injection

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record

Locations